Molecularly targeted therapies for p53-mutant cancers

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• The tumor suppressor p53 is frequently lost or mutated in human cancers.
• Mutant p53 often acquires oncogenic functions, promoting tumor progression and drug resistance.
• Cancer cells with mutant p53 may rely on specific secondary genes or pathways for survival.

Purpose of the Study:

• To review and discuss strategies for targeting mutant p53.
• To explore direct targeting of mutant p53 protein.
• To examine progress in identifying vulnerabilities in p53-mutant cancer cells.

Main Methods:

• Literature review of current research on mutant p53 targeting strategies.
• Analysis of studies focusing on direct mutant p53 inhibition.
• Evaluation of research on synthetic lethality and pathway dependencies in p53-mutant cancers.

Main Results:

• Traditional strategies aim to deplete mutant p53 or restore its tumor-suppressive function.
• Targeting secondary genes or pathways offers an indirect therapeutic approach for p53-mutant cancers.
• Mutant p53 exhibits gain-of-function activities that promote tumor growth and metastasis.

Conclusions:

• Targeting mutant p53 directly or indirectly presents promising therapeutic avenues.
• Exploiting functional dependencies in p53-mutant cells provides alternative treatment strategies.
• Understanding mutant p53's gain-of-function roles is crucial for developing effective cancer therapies.